Document is current

Any future updates will be listed below

647 Evaluation of efficacy and toxicity of CD137 immunotherapy with urelumab-mIgG1 chimeric antibody in CD137 HuGEMM™

Crossref DOI link: https://doi.org/10.1136/jitc-2020-SITC2020.0647

Published Online: 2020-11-09

Published Print: 2020-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark